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Abstract
Fused Deposition Model (FDM) as Additive manufacturing (AM) technologies may offer a viable and simpler alternative to manufacture
scaffolds for different purposes such as tissue engineering and cells culture. Existing commercial FDM machines are currently being modified 
to improve their accuracy, capabilities and use. However, for biocompatible and/or bioimplantable materials such as Poli (ɛ -caprolactone) PCL
there is still a lot of work to do to set up process parameters. Cells culture had been carried on 2D without being a proper and real midst. In fact 
cells do not grow only in two flat directions but in all directions making strong net. Since cells responses to proteins or drugs is important for 
knowing proliferation or enrichment more real culture in 3D is needed. This work focuses on the study and optimization of open-source 3D 
printer machine, called RepRap, employed to manufacture biocompatible scaffolds for 3D cells culture of Triple-Negative Breast Cancer 
(TNBC). It has been shown that scaffolds culture can enhance the Cancer Stem Cell (CSC) population, responsible in part for tumour 
recurrence after chemotherapy. Mammosphere Forming Index (MFI) was defined in all cell lines to evaluate this population in TNBC cell lines 
sensible and resistant to chemotherapy. Enriching TNBC cells with CSC after scaffold culture will help to study new therapeutic treatments 
directed to this population. Several process parameters are tested to manufacture scaffolds and cells culture had been carried out in order to 
validate the results. Results show that porosity plays an important role in scaffolds manufacture having low cells adhesion and growth. Lower 
porosity values should be tested to further evaluate MFI index after scaffold culture as cell growth and enrichment indication.
© 2015 The Authors. Published by Elsevier B.V.
Peer-review under responsibility of the scientific committee of The Second CIRP Conference on Biomanufacturing.
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1. Introduction
Cell culture is a technique widely used in cancer research 
laboratories, for instance to the study of cancer biology and 
the development of new therapeutic strategies. Nowadays, 2D 
cell culture is the most frequent technique used. Although 
interest for 3D cell culture is emerging because cell 
architecture and interactions simulates better the biology of a
tissue compared to the flat-growing 2D systems [1].
The development of accurate constructs made of a matrix 
or scaffold and living cells to repair and regenerate damaged 
tissue is a current challenge in the tissue engineering field [2].
Taking advantage of this, scaffold fabrication for 3D cell-
culture has emerged using technologies already developed for 
this purpose. One of these techniques is the additive 
manufacturing technology, which enables the fabrication of 
customized scaffolds directly from the patient. For this 
purpose, existing additive manufacturing machines are 
currently being modified to improve their accuracy and 
capabilities. The optimization of process parameters is a 
major challenge to obtain adequate scaffold morphology and 
biomechanical behavior, which are to improve cell adhesion 
and proliferation. Indeed, appropriate porosity, pore size, pore 
shape, and mechanical strength are required to achieve cell 
growth and matrix formation [3]. Open source extruders, like 
the RepRap machine, allow a thorough study of several 
process parameters involved in the fabrication of scaffolds
such as deposition speed, layer thickness, filament distance,
deposition pattern, extrusion and bed temperatures and speed 
movement. Therefore, a precise control over this 
manufacturing process is required.
© 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Triple-Negative Breast Cancer (TNBC) is a type of breast 
cancer which runs an aggressive course and has a poor 
prognosis. It shows the highest recurrence rate compared to 
other breast cancer types [4]. TNBC lacks of validated 
directed therapy, and patients are treated mainly with 
chemotherapy (anthracyclines and taxans). Even though 
TNBC shows a good response to these therapies, recurrence at 
5 years following diagnosis is about 30% of the cases [5,6].
Recent studies showed that chemoresistance can be 
achieved by a unique and rare cell niche with stemness 
features, the so-called Cancer Stem Cells (CSC) [7,8]. These 
cells, capable of tumor initiation, are not only responsible for 
tumor recurrence, but also metastasis [9]. Interestingly, 
scaffolds not only allow cells to interact in a 3D way 
improving the in-vitro 2D system, but also it has been 
described that 3D cultures can enhance the CSC population 
[10,11].
In this study it had been investigated the optimization of 
the open source and low-cost 3D extruder machine RepRap, 
employed to fabricate PCL scaffolds suitable for 3D cell 
culture. Design and manufacturing parameters were 
determined to ensure the best performance. In addition, this 
work focuses in 3D scaffolds ability to enrich the CSC 
population for developing new therapeutic strategies to target 
this population.  
2. Materials and Methods
2.1. Material
A 3mm Poli(ɛ-caprolactone) (PCL) wire (Perstorp, Malmö, 
Sweden) was used to manufacture the scaffolds. PCL is 
biodegradable polyester proven to be biocompatible and free 
of toxic dye.
2.2. 3D printer machine and software
Printer machine RepRap BCN 3D+ was used to produce 
three-dimensional scaffolds. It is an open source and modular 
3D printer designed by RepRap BCN. This printer uses the 
Fused Filament Fabrication (FFF) technology so called Fused 
Depostion Model (FDM). The filament unwound from a coil 
is supplied to the extruder. Then, at certain temperature and 
pressure, exerted by a gear, causes the extrusion of the 
material through the nozzle, which is finally deposited onto a 
heated computer-controlled Cartesian platform.
The scaffold’s design was carry out with the computer-
aided design (CAD) software SolidWorks. The designs were 
saved in STL file formats, which are transferred to a 
computer-aided manufacturing (CAM) software called Slic3r. 
This program was used for establishing the printing 
parameters. It generates G-code files able to command and 
control the machine in order to obtain the scaffolds printed.
Table 1 shows the process parameters utilized for the 
experimental set up. Design parameters, such as shape, layer 
thickness, diameter of filament and distance between 
filaments, were studied and analysed. Deposition angle
between layers was fixed at 0-90º. Shape refers to the basic 
feature of the scaffold produced. Thickness is the total height 
of the scaffold and the distance between filaments is the 
shortest distance between two filaments located within the 
same layer. 
Table 1. Scaffold parameters and levels tested in order to obtain the optimal 
printing
 Parameters Levels









 Deposition angle (º) 0-90
Shape square, round
Thickness (mm) 1.8, 3.6
Diameter of filament (mm) 0.175, 0.30, 0.50
Distance between filaments (mm) 0.5, 0.7,  1














Deposition speed (mm/s) 10, 20, 30, 50
Layer height (mm)
0.15, 0.20, 0.25, 0.28, 
0.30, 0.35
Extrusion temperature (ºC)
65, 75, 80, 85, 90, 95,  
105, 110, 115, 120, 130, 
150, 155, 160, 180, 200
Bed temperature (ºC) 25, 30, 33, 35, 37
Other parameters were set, like deposition speed, layer 
height and temperatures. The deposition speed was defined as 
the speed for printing movements of the extruder. Layer 
height is the distance between two connected layers along the 
Z axis. Finally, temperatures of the extruder and the glass 
platform were set up as well.
2.3. Cell Culture
MCF-7, MDA-MB-231 and HCC1806 breast carcinoma 
cells were obtained from the American Type Culture 
Collection (ATCC, Rockville, MD, USA). MDA-MB-231 and 
HCC1806 are cell lines established from patients with TNBC.
MCF-7 are a HER2 positive cell line, (a type of breast cancer 
that overexpresses the Human Epidermal Growth Factor 
Receptor 2), used for scaffold validation. Doxorubicin 
(chemotherapeutic drug) was used to create resistant models 
from MDA-MB-231 (231DXR) and HCC1806 (HCCDXR) in 
our laboratory by treating cells at increasing doses of 
doxorubicin for 48 hours periods until 6 months.
MCF-7, and MDA-MB-231 and 231DXR cells were 
cultured in DMEM (Dulbecco’s Modified Eagle’s Medium)
(Gibco, Walthman, MA, USA) supplemented with 10% fetal 
bovine serum, 1% L-glutamine, 1% sodium pyruvate,
50U/mL penicillin and 50µg/mL streptomycin (HyClone,
Logan, UT, USA). HCC1806 and HCCDXR cells were 
cultured in RPMI (Roswell Park Memorial Institute) (Gibco, 
Walthman, MA, USA) and supplemented as above. All cells 
were maintained at 37ºC and 5% CO2 atmosphere. 
2.4. Mammosphere-forming assay
In order to evaluate CSC population, the mammosphere-
forming technique was performed (Figure 1). Cells from 2D 
or PCL scaffolds were removed by trypsinitzation. Then cells 
were counted, and seeded into a 6-well cell culture microplate
coated with pHEMA using DMEM/F12 medium 
supplemented with B27, EGF and FGF (20ng/mL), 1% L-
glutamine, 1% sodium pyruvate and 25U/mL penicillin and 
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25µg/mL streptomycin . Finally, cells were incubated for 5 or 
7 days and mammospheres bigger than 50µm were counted 
using an inverted opical microscope. Mammosphere Forming 
Index (MFI) was calculated using the formula described
below:
     
Figure 1. Mammosphere-forming assay protocol
For the mammosphere treatment experiments, doxorubicin 
was added in the seeding process. Mammosphere Forming 
Inhibition (MFIn) was calculated, as shown in the formula 
below:
      
2.5. Growth inhibition assay
MDA-MB-231, HCC1806, 231DXR and HCCDXR were 
plated out at a density of 5x103 cells/2mL/well in 6-well 
plates. Posterior overnight cell adherence, fresh medium 
along with the corresponding doxorubicin concentration was
added to the cultures. Following treatment, media was 
replaced by drug-free medium (1mL/well) containing MTT 
(3,4,5-dimetylthiazol-2-yl-2,5-diphenyltetraolim bromide, 
Sigma) solution, and incubation was prolonged for 2 hours at 
37ºC. Formazan crystals formed by metabolically viable cells 
were dissolved in DMSO (300µL/well) and absorbance was 
determined at 570nm in a multi-well plate reader (Model 
Anthos Labtec 2010 1.7). Using control OD values (C) and 
test OD values (T), % of Cell Proliferation Inhibition (CPI)
was calculated from the equation below:
      
Data presented are from two separate wells per assay and 
the assay was performed at least three times.
2.6. Scaffold sterilization
Scaffolds were sterilized with 70% ethanol/water solution 
overnight, washed with PBS (Gibco, Walthman, MA, USA)
and finally exposed to UV light for 90 minutes.
2.7. Cell culture in scaffolds
Scaffolds were placed into a 12-well cell culture 
microplate. First, 250µL of cell suspension (10.000-100.000 
cells) were placed onto the centre of its surface to allow cells
attach on the scaffold. After 1 hour incubation period, 1.5mL 
of fresh medium was added to cover the scaffold. Cells were 
incubated for 72 hours and then counted. (Figure 2).
Figure 2. Cell seeding protocol on PCL scaffolds.
To quantify the cells attached, the scaffold was placed in a 
new well, washed with PBS and 1mL of trypsin was added. 
After incubation, 2.5mL of fresh medium were added and the 
cell suspension was collected and centrifuged at 1500rpm for 
5 min. Finally, the supernatant was discarded and cells were 
counted using a Neubauer Chamber and an inverted optical 
microscope. The same procedure was done to obtain the cells 
attached at the well where the scaffold was placed.
2.8. Statistical analysis
All data are expressed as mean ± standard error (SE). Data 
were analyzed by Student t test. Statistical significant levels 
were p < 0.05 (denoted as *), p < 0.01 (denoted as **) and p < 
0.001 (denoted as ***). p-value is shown in results when 
significance is reached (p < 0.05). 
3. Results
3.1. Scaffolds design and manufacturing
Scaffolds were designed with a round shape, with the size 
of 19mm diameter to allow their use in regular cell culture 
plate-dishes of 12 wells. The final designs had 1.8mm of 
thickness, composed of 6 different layers of polymeric 
material, being 0.3mm of thickness each layer. The distance 
between filaments was 0.7mm and the deposition angle was 
established at 0-90º (Table 2).
Scaffolds manufacturing parameters were optimized by 
screening experiments to print the scaffolds efficiently and 
properly for cells culture (Table 3).
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The deposition speed took a small value to optimize the 
material’s deposition. The nozzle tip size was fixed at 
0.35mm. The printed filaments had a diameter of 0.30mm. 
With visual screening, it was proved that the optimal 
extrusion temperature was 85ºC (Figure 3). Finally, scaffolds
were fabricated with a bed temperature of 35ºC, to guarantee 
their adhesion to the printing platform.
Table 2. Scaffold desig parameters.
Parameters
Diameter 19mm
Shape Round
Thickness
Number of layers
Distance between filaments
Deposition angle
1.8mm
6
0.7mm
0-90º
Diameter of filament 0.30mm
Table 3. Scaffold manufacturing parameters
Parameters
Deposition velocity 10mm/s
Layer height 0.30mm
Nozzle tip size 0.35mm
Extrusion temperature 85ºC
Bed temperature 35ºC
(a) (b) (c)
Figure 3. Scaffold manufacturing at different extrusion temperature (a) 80ºC,
(b) 85ºC, (c) 90ºC.
3.2. Cancer Stem Cells population characterization
Cancer Stem Cells are a very rare population within the 
tumor. These cells have been demonstrated to have the ability 
to survive and propagate in a non-adherent way, forming 
spheres called mammospheres [7,12,13].
To determine CSC population, the mammosphere-forming 
assay was performed in cell lines MCF-7, MDA-MB-231, 
HCC1806, and resistant models 231DXR and HCCDXR
(Figure 4). MFI was then calculated (Table 4).
CSC represents a small population in all cell lines, with 
values ranging from 0.67% to 2.47% of MFI. When 
comparing the ability to form mammosphere between parental 
and resistant cells to doxorubucin, no increase of MFI was 
observed in the two models.
Figure 4. Mammospheres under optic microscope for MCF-7, MDA-MB-231
and HCC1806.
Table 4. Mammosphere Forming Index (MFI).
Cell Line
Cells seeded
(cells/well)
Days MFI (%) 
MCF-7 2.000 7 2.47±0.26
MDA-MB-231
HCC1806
231DXR
HCCDXR
5.000
5.000
5.000
5.000
5
5
5
5
1.78±0.24
0.92±0.17
1.75±0.27
0.67±0.04
Data are shown as mean ±SEM.
As cell plasticity plays an important role in tumor biology 
and drug resistance, it was checked the ability to form 
mammospheres under doxorubicin pressure [14-16]. To do so, 
the experiments were repeated in presence of doxorubicin in 
both sensible and resistant cell lines and MFIn was calculated 
for each model. The same experiment was performed in 
adherent conditions using the MTT assay as described in 
Material and Methods section. Intrinsic resistance of CSC to 
doxorubicin was observed in all models (Figure 4). In 
adherent conditions, cell lines proliferation inhibition (% CPI)
ranged from 84.2% to 89.5%. Otherwise, MFIn values
showed significant lower inhibition in all cell lines, ranging 
from 20.6% to 60.7% (p-values < 0.001).
Figure 5. Proliferation inhibition and Mammposphere forming inhibition
(MFIn) under doxorubicin treatment for 5 days. (a) MDA-MB-231 and 
231DXR with doxorubicin (70nM). (b) HCC1806 and HCCDXR with 
doxorubicin (140nM). Experiments were performed at least three times in 
duplicate. *(p < 0.05), **(p < 0.01) and ***(p < 0.001) indicate levels of 
statistically significance.


 	
a) b)
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The cytotoxic effect of doxorubicin was then 
evaluated in CSC population comparing parental and resistant 
models (Figure 4). MDA-MB-231 and 231DXR showed an 
MFIn of 60.66% and 51.29% (p value: 0.005) respectively. 
HCC1806 MFIn was 51.97% and 20.61% for HCCDXR (p
value: 0.036). CSC population from resistant models 
HCCDXR and 231DXR showed significance resistant to 
doxorubicin, maybe due to an enrichment of this population in 
this models [8].
3.3. Scaffolds and cell culture 
The scaffold with deposition angles of 0-90º (Figure 2a) 
was printed and tested for cell culture (Figure 5).
Figure 5.  Scaffold fabricated with RepRap Machine a) 19mm diameter, 
1.8mm thick, and deposition angles of 0-90º b) the scaffold plated in a 12 
well-plate.
Before its use, scaffolds were sterilized as mentioned in 
Material and Methods section. Then MCF-7 cells were seeded 
at different densities (10.000, 50.000 and 100.000 cells/well) 
during 72 hours. Attached and non-attached cells were 
counted.
Figure 6. Optical microscope images of MCF-7 cells attached at the 
bottom of the well. Scaffold fiber has been drawn on the top.
In this first attempt, no cells were attached to the scaffold. 
As it was described and then observed under the microscope, 
this scaffold has large pores. The fibers of the different layers 
have the same disposition angle and, for that reason, cells can 
easily fall to the bottom of the well before they can get 
attached to PCL fibers (Figure 6).
As PCL fibers have already been tested in cell culture [10],
new goal is set up focusing on designing and testing new 
scaffolds with different deposition angles between layers to 
achieve different and smaller pore sizes. 
Two more designs have been performed, where the 
deposition angles were variable, taking the values of 0-60-
120º and 0-45-90-135º (Figure 7). The variation of the angle 
deposition between layers results in a different pore size and 
shapes between the scaffolds (Table 5).
Figure 7. Scaffolds designs with different deposition angles: (a) 0-90º, (b) 
0-60-120º, (c) 0-45-90-135º.
Table 5. Pore characteristics depending on the deposition angle
Deposition angles Pores shape Area
0-90º
0-60-120º
0-45-90-135º 
Square
Equilateral triangle
6 variable forms
(triangles and irregular polygons)
0.15mm2
0.1256mm2
1.98x10-4 to 
0.13mm2
4. Conclusions
In this study, the parameters of the open source RepRap 
3D printer have been optimized to fabricate scaffolds of PCL
suitable for cell culture.
Parameters, like deposition speed, diameter of the filament 
and extrusion and bed temperatures have been determined to 
obtain an optimal manufacture.
Design parameters, such are round shape, diameter and 
thickness were thought to allow its use in regular 12 well-cell 
culture plates. Three different designs have been performed, 
with different angles between layers, obtaining different pores 
sizes in all designs.
MCF-7 and TNBC cell lines had the ability to form 
mammospheres with low values of MFI, showing that CSC 
represents a very small population in these cell lines. CSC 
enriched population showed also intrinsic resistance to 
chemotherapy when compared to adherent culture. On the 
other hand, CSC population in resistant cell models developed 
in our lab (HCCDXR and 231DXR) showed increased ability 
to form mammospheres compared to the parental models
under doxorubicin treatment.
MCF-7 cell line was used to test the scaffolds printed with 
deposition angles of 0-90º. Because of the same distribution 
of the fibers between layers and the large pores size of this 
design, cells drifted at the bottom of the well without 
attaching the scaffold. The other two designs, with smallest 
pore size will be tested in further studies.
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